Strong evidence that HPV vaccination protects against cervical pre-cancer, review finds

11:56 EDT 27 Jun 2018 | The Pharmaceutical Journal

There is strong evidence that vaccination against human papillomavirus (HPV) between the ages of 15 and 26 years protects against cervical pre-cancer in young women, concluded the authors of a recent Cochrane Review (9 May 2018).

Strong evidence that HPV vaccination protects against cervical pre-cancer, review finds

More From BioPortfolio on "Strong evidence that HPV vaccination protects against cervical pre-cancer, review finds"